title: [Ultra-high dosage lysis of deep venous thrombosis in ipsipedal administration along with compression].
abstract: The ipsipedal application of UHSK leads to a decisive increase of recanalisation. The fibrinolyticum will be brought in a greater quantity to the thrombotic region. The adjuvant supramalleolar compression and the increase of volume seems to be beneficial. The promising results of thrombolysis at elder thrombosis justify a late fibrinolysis, which is profitable too, for patients with early postoperative thrombosis at the end of the first wound healing phase.
authors.affiliation: Radiologie, Marien-Hospitals Witten.
authors.forename: W
authors.initials: W
authors.lastname: Dembinski
authors.forename: C
authors.initials: C
authors.lastname: Kohl
authors.forename: R
authors.initials: R
authors.lastname: Geisbüsch
authors.forename: L
authors.initials: L
authors.lastname: Rickels
authors.forename: J R
authors.initials: JR
authors.lastname: Neitzel
authors.forename: F
authors.initials: F
authors.lastname: Loncarevic
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001458:Bandages; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013300:Streptokinase / Q000008:administration & dosage*; D013924:Thrombophlebitis / Q000628:therapy*
chemical_list: D013300:Streptokinase
vernacular_title: UHSK-Lyse tiefer Venenthrombosen bei ipsipedaler Applikation unter Kompressionsbedingungen.